Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28,736,767
-
Number of holders
-
197
-
Total 13F shares, excl. options
-
23,530,792
-
Shares change
-
+4,072,895
-
Total reported value, excl. options
-
$1,808,818,954
-
Value change
-
+$346,627,584
-
Put/Call ratio
-
59%
-
Number of buys
-
140
-
Number of sells
-
-49
-
Price
-
$76.86
Significant Holders of GeneDx Holdings Corp. - Common Stock (WGS) as of Q4 2024
228 filings reported holding WGS - GeneDx Holdings Corp. - Common Stock as of Q4 2024.
GeneDx Holdings Corp. - Common Stock (WGS) has 197 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23,530,792 shares
of 28,736,767 outstanding shares and own 81.88% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (3,507,164 shares), Corvex Management LP (2,473,781 shares), BlackRock, Inc. (1,179,812 shares), GOLDMAN SACHS GROUP INC (1,143,491 shares), ORACLE INVESTMENT MANAGEMENT INC (1,023,468 shares), VANGUARD GROUP INC (1,006,210 shares), SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC (755,564 shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (669,995 shares), LORD, ABBETT & CO. LLC (630,473 shares), and FRED ALGER MANAGEMENT, LLC (546,054 shares).
This table shows the top 197 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.